Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Patricia Lo Russo"'
Autor:
T.R. Jeffry Evans, Maurizio Voi, Shruti Agrawal, Prashni Paliwal, Valerie G. Brunton, Jeffrey A. Morgan, Ding Wang, Iain R.J. MacPherson, Patricia Lo Russo, George D. Demetri
Supplementary Data from Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e06c2f09e172de59a9655afbe26c21e
https://doi.org/10.1158/1078-0432.22440253
https://doi.org/10.1158/1078-0432.22440253
Autor:
T.R. Jeffry Evans, Maurizio Voi, Shruti Agrawal, Prashni Paliwal, Valerie G. Brunton, Jeffrey A. Morgan, Ding Wang, Iain R.J. MacPherson, Patricia Lo Russo, George D. Demetri
Purpose: To determine the maximum tolerated dose, dose-limiting toxicity (DLT), and recommended phase II dose of dasatinib in metastatic solid tumors refractory to standard therapies or for which no effective standard therapy exists.Experimental Desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::735eef4e2da338a45ef9202bee0418c9
https://doi.org/10.1158/1078-0432.c.6517603
https://doi.org/10.1158/1078-0432.c.6517603
Autor:
Iain R. Macpherson, Patricia Lo Russo, T.R. Jeffry Evans, George D. Demetri, Prashni Paliwal, Shruti Agrawal, Valerie G. Brunton, Jeffrey A. Morgan, Maurizio Voi, Ding Wang
Publikováno v:
Clinical Cancer Research. 15:6232-6240
Purpose: To determine the maximum tolerated dose, dose-limiting toxicity (DLT), and recommended phase II dose of dasatinib in metastatic solid tumors refractory to standard therapies or for which no effective standard therapy exists. Experimental Des